当前位置: X-MOL 学术Front. Cell Dev. Biol. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Pre-treatment With Ranibizumab Aggravates PDT Injury and Alleviates Inflammatory Response in Choroid-Retinal Endothelial Cells.
Frontiers in Cell and Developmental Biology ( IF 4.6 ) Pub Date : 2020-06-19 , DOI: 10.3389/fcell.2020.00608
Yang Liu 1, 2 , Min Zhu 1, 2 , Ruowen Gong 1, 2 , Xin Wang 1, 2 , Lei Li 1, 2 , Gezhi Xu 1, 2
Affiliation  

Polypoidal choroidal vasculopathy (PCV) is the predominant subtype of exudative age-related macular degeneration in Asians. Although photodynamic therapy (PDT) is widely used for PCV treatment, its long-term beneficial effects are unsatisfactory. Accumulating clinical investigations suggest that combined therapy with anti-vascular endothelial growth factor (anti-VEGF) and PDT is superior to PDT monotherapy. However, the optimal time of anti-VEGF before or after PDT remains controversial, hence it needs to further explore the mechanism underlying combined therapy. PDT causes selective damage to endothelial cells, which determines its angio-occlusive efficiency, yet the impact of anti-VEGF on PDT-induced endothelial injury is unclear. Here, we found that pre- compared to post-treatment with anti-VEGF ranibizumab (rani) significantly aggravates PDT injury in the rhesus macaque choroid-retinal endothelial (RF/6A) cell line. PDT activates apoptosis, necroptosis and NLRP3 inflammasome in RF/6A cells. Pre-treatment with rani promotes PDT-caused apoptosis via triggering caspase 8-mediated extrinsic apoptosis, and caspase 8 might also play a pivotal role in the rani’s function of suppressing PDT-induced necroptosis and NLRP3 inflammasome activation. Our results implicate that pre-treatment with rani may enhance the angio-occlusive efficiency of PDT and alleviate endothelial inflammatory response, which gives it a great advantage over post-treatment.



中文翻译:

雷尼单抗的预处理可加重PDT损伤并减轻脉络膜-视网膜内皮细胞中的炎症反应。

息肉样脉络膜血管病(PCV)是亚洲人与年龄相关的渗出性黄斑变性的主要亚型。尽管光动力疗法(PDT)已广泛用于PCV治疗,但其长期有益效果仍不能令人满意。越来越多的临床研究表明,抗血管内皮生长因子(anti-VEGF)和PDT的联合治疗优于PDT单一疗法。然而,PDT之前或之后抗VEGF的最佳时间仍存在争议,因此需要进一步探讨联合治疗的机制。PDT对内皮细胞造成选择性损伤,这决定了它的血管闭塞效率,但抗VEGF对PDT诱导的内皮损伤的影响尚不清楚。这里,我们发现,与抗VEGF雷珠单抗(rani)进行治疗后相比,猕猴猕猴脉络膜-视网膜内皮细胞(RF / 6A)的PDT损伤明显加重。PDT激活RF / 6A细胞的凋亡,坏死性坏死和NLRP3炎性小体。用rani预处理可通过触发caspase 8介导的外在凋亡来促进PDT引起的凋亡,而caspase 8可能在rani抑制PDT诱导的坏死病和NLRP3炎症小体激活中起关键作用。我们的结果表明,兰尼预处理可以增强PDT的血管闭塞效率并减轻内皮炎症反应,这比后处理具有更大的优势。坏死和RF / 6A细胞中的NLRP3炎性小体。用rani预处理可通过触发caspase 8介导的外在凋亡来促进PDT引起的凋亡,而caspase 8可能在rani抑制PDT诱导的坏死病和NLRP3炎症小体激活中起关键作用。我们的结果表明,兰尼预处理可以增强PDT的血管闭塞效率并减轻内皮炎症反应,这比后处理具有更大的优势。坏死和RF / 6A细胞中的NLRP3炎性小体。用rani预处理可通过触发caspase 8介导的外在凋亡来促进PDT引起的凋亡,而caspase 8可能在rani抑制PDT诱导的坏死病和NLRP3炎症小体激活中起关键作用。我们的结果表明,兰尼预处理可以增强PDT的血管闭塞效率并减轻内皮炎症反应,这比后处理具有更大的优势。

更新日期:2020-07-09
down
wechat
bug